Clinical Trial Detail

NCT ID NCT03438708
Title Prior Axitinib as a Determinant of Outcome of Renal Surgery (PADRES)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Diego
Indications

clear cell renal cell carcinoma

Therapies

Axitinib

Age Groups: adult senior

No variant requirements are available.